About Beyond Gender European Evidence
European evidence, country by country
This site records what European health authorities, courts and legislatures have decided about gender medicine and sex-based rights, one country at a time, with dates and sources.
Purpose
Europe is where the evidence base for youth gender medicine was built and where it was first re-examined. Finland's COHERE council, Sweden's Karolinska hospital and SBU agency, Norway's UKOM investigation board, the Dutch Amsterdam clinic and the French, German and Danish bodies that followed have each produced documents that are cited everywhere and read rarely. This site catalogues them.
How it is organised
Country dossiers each cover one national system: what it did, what it reviewed, what it changed and when. Cross-cutting dossiers cover the Dutch protocol, the systematic reviews and the European courts. The European timeline places every decision in order. The sources page collects the reviews, guidelines and judgments, with links to the originals in their own languages where available and to English translations where they exist.
Standards
Facts and dates first. Interpretation is marked as interpretation. National documents are preferred to press summaries. Corrections are welcome with a link to the original.
Point of view and publisher
The site is gender-critical. It regards the Nordic systematic reviews as the best evidence available and the Dutch protocol as an experiment whose own follow-up data did not support its export. It is published by Genspect, the international organisation founded in Ireland in 2021 with chapters across Europe, whose founder Stella O'Malley hosts the Beyond Gender podcast with Mia Hughes and Dr Bret Alderman.
Dossiers on clinics and therapy
Sweden: Karolinska, SBU and the 2022 guidelines
Sweden’s change was not the result of a new Act of Parliament banning medical transition for minors. It was a sequence of clinical and national evidence-policy decisions. The first was local: Astrid Lindgren Children’s Hospital, part of Karolinska University Hospital in Stockholm, altered its practice in spring 2021. The second was national: Socialstyrelsen, Sweden’s National Board of Health and Welfare, revised its recommendations for under-18s in 2022 after commissioning an evidence review from SBU, the Swedish Agency for Health Technology Assessment and Assessment of Social Services.
Germany: the S2k guideline and the self-determination law
Germany’s position is frequently presented as a direct answer to the Nordic reappraisals of paediatric gender medicine. That is only partly accurate. Germany has two distinct policy tracks: a clinical guideline for assessment and treatment, and a civil-status law on the legal recording of sex and names. The two are politically connected in public debate, but legally separate.